The provided source details the transformation of 23andMe, a personal genomics company, following its Chapter 11 bankruptcy filing. Anne Wojcicki, the co-founder, reacquired the company through her non-profit organization, TTAM Research Institute, outbidding a competitor. This strategic move signifies a shift from a for-profit public entity to a non-profit structure, aiming to prioritize data privacy and public benefit over short-term shareholder gains. The article suggests this rebirth could reinvigorate the personal genomics industry by fostering greater trust and enabling the realization of Wojcicki's long-held vision for genetic data as a public asset for health and scientific advancement.